相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Prognostic Value of Tumor Proportion Score in Salivary Gland Carcinoma
Fumihiko Sato et al.
LARYNGOSCOPE (2021)
The tumor immune contexture of salivary duct carcinoma
Gustavo Schvartsman et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2021)
Progress and Challenges of Predictive Biomarkers for Immune Checkpoint Blockade
Yanna Lei et al.
FRONTIERS IN ONCOLOGY (2021)
Mucoepidermoid carcinoma of salivary glands: A French Network of Rare Head and Neck Tumors (REFCOR) prospective study of 292 cases
Laurie Saloner Dahan et al.
EJSO (2021)
The PD-L1/PD-1 Axis Blocks Neutrophil Cytotoxicity in Cancer
Olga Yajuk et al.
CELLS (2021)
Programmed death ligand-1 expression is associated with stage and histological grade of parotid carcinoma
Masaaki Higashino et al.
ACTA OTO-LARYNGOLOGICA (2020)
Prognostic Impact of PD-L1 Expression in Malignant Salivary Gland Tumors as Assessed by Established Scoring Criteria: Tumor Proportion Score (TPS), Combined Positivity Score (CPS), and Immune Cell (IC) Infiltrate
Hanno M. Witte et al.
CANCERS (2020)
Major and minor salivary gland tumours
Gemma Gatta et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)
Prognostic impact of CD8-positive tumour-infiltrating lymphocytes and PD-L1 expression in salivary gland cancer
Nikolina Kesar et al.
ORAL ONCOLOGY (2020)
Prognostic value of programed death ligand-1 and ligand-2 co-expression in salivary gland carcinomas
Takafumi Nakano et al.
ORAL ONCOLOGY (2019)
Predictors of distant metastasis in parotid acinic cell carcinoma
Qigen Fang et al.
BMC CANCER (2019)
PD-L1 expression by immunohistochemistry in salivary duct carcinoma
Ameer Hamza et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2019)
Oncologic outcome and potential prognostic factors in primary squamous cell carcinoma of the parotid gland
Qigen Fang et al.
BMC CANCER (2019)
Prognostic markers in salivary gland cancer and their impact on survival
Mateusz Szewczyk et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2019)
The immune microenvironment and expression of PD-L1, PD-1, PRAME and MHC I in salivary duct carcinoma
Bin Xu et al.
HISTOPATHOLOGY (2019)
The expression of PD-L1 in salivary gland carcinomas
Domenic Vital et al.
SCIENTIFIC REPORTS (2019)
Comparison of Different Antibody Clones for Immunohistochemistry Detection of Programmed Cell Death Ligand 1 (PD-L1) on Non-Small Cell Lung Carcinoma
Edwin R. Parra et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2018)
The expression of programed death ligand-1 could be related with unfavorable prognosis in salivary duct carcinoma
Fumihiko Sato et al.
JOURNAL OF ORAL PATHOLOGY & MEDICINE (2018)
Heterogeneous expression of PD-L1 in pulmonary squamous cell carcinoma and adenocarcinoma: implications for assessment by small biopsy
Thomas J. Gniadek et al.
MODERN PATHOLOGY (2017)
Programmed Death Ligand-1 Expression Is Associated With Poor Disease Free Survival in Salivary Gland Carcinomas
Takashi Mukaigawa et al.
JOURNAL OF SURGICAL ONCOLOGY (2016)
Prognostic factors and survival rates for parotid duct carcinoma patients
Shuang Shi et al.
JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY (2014)